09:04 AM EDT, 10/03/2025 (MT Newswires) -- Health care stocks were advancing premarket Friday, with the Health Care Select Sector SPDR Fund (XLV) and the iShares Biotechnology ETF (IBB) both up 0.3%.
Mesoblast (MESO) shares were up more than 7% after the company said US Medicare & Medicaid Services has assigned a J-Code to graft-versus-host disease treatment Ryoncil. The permanent J-Code, J3402, facilitates reimbursement and broader patient access for the drug, Mesoblast said.